Project Name：Repaglinide metformin 

Registration Classification：3.2

Formulations and specifications ：Tablets: 1mg/500mg, 2mg/500mg 

Indications：Treatment type Ⅱ diabetes which the blood sugar can not be controled by any kind of medication .

Original Research Company：Novo Nordisk 

Progress：Collating information , preparing submitted to the State Bureau